发明申请
US20130005703A1 QUINOLINE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE SEROTONIN-5-HT6 RECEPTOR
有权
适用于治疗调节SEROTONIN-5-HT6受体的病症的喹啉化合物
- 专利标题： QUINOLINE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE SEROTONIN-5-HT6 RECEPTOR
- 专利标题（中）： 适用于治疗调节SEROTONIN-5-HT6受体的病症的喹啉化合物
-
申请号： US13613344申请日： 2012-09-13
-
公开(公告)号： US20130005703A1公开(公告)日： 2013-01-03
- 发明人: Sean Colm Turner , Wilfried Braje , Andreas Haupet , Udo Lange , Karla Drescher , Karsten Wicke , Liliane Unger , Mario Mezler , Matthias Mayrer , Wolfgang Wernet , Andrea Nager-Wernet
- 申请人： Sean Colm Turner , Wilfried Braje , Andreas Haupet , Udo Lange , Karla Drescher , Karsten Wicke , Liliane Unger , Mario Mezler , Matthias Mayrer , Wolfgang Wernet , Andrea Nager-Wernet
- 优先权： EP07113962.0 20070807
- 主分类号： A61K31/4709
- IPC分类号： A61K31/4709 ; A61P25/28 ; A61P25/00 ; A61P25/30 ; A61P3/04 ; A61K31/475 ; A61P25/18
摘要：
The present invention relates to novel quinoline compounds of the formula (I) and to the salts thereof. The compounds possess valuable therapeutic properties and are particularly suitable, for treating diseases that respond to modulation of the serotonin 5-HT6 receptor. In formula (I) R is a moiety of the formula (R) wherein * indicates the binding site to the quinolinyl radical and wherein A, B, X′, Y, Q, R1, R2, R3, R4, R5, m, n, p, q, Ra, Rb, X and Ar are as defined in claim 1.
公开/授权文献
信息查询
IPC分类:
